Showing results (101-110 of 146) with videos related to
Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantationJohn E Levine, Thomas Braun, Samuel L Penza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupRichard Aplenc, Todd A Alonzo, Robert B Gerbing, et al.Pediatric Blood & Cancer|September 11, 2013
Oxandrolone for the treatment of bone marrow failure in Fanconi anemiaSusan R Rose, Mi-Ok Kim, Leslie Korbee, et al.Journal of Clinical and Translational Science|May 5, 2021
The Access Technology Program of the Indiana Clinical Translational Sciences Institute (CTSI): A model to facilitate access to cutting-edge technologies across a stateChristie M Orschell, Todd C Skaar, Melanie E DeFord, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 18, 2023
Implementation of a gene therapy education initiative by the ASGCT and Muhimbili University of Health and Allied SciencesKenneth Cornetta, Samantha Kay, Florence Urio, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2010
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantationLindsay L Rosenbeck, Patrick J Kiel, Iftekhar Kalsekar, et al.Genomics|August 10, 2010
Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse modelDaniel P Heruth, Troy Hawkins, Derek P Logsdon, et al.Blood|May 12, 2005
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemiaRobert J Arceci, Jane Sande, Beverly Lange, et al.Human Gene Therapy|September 10, 2016
Lentivirus Mediated Correction of Artemis-Deficient Severe Combined ImmunodeficiencyDivya Punwani, Misako Kawahara, Jason Yu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology groupRoland B Walter, Todd A Alonzo, Robert B Gerbing, et al.Pageof 15